May 31 |
SciSparc Secures Strategic Advantage with Grant of European Patent
|
Apr 11 |
SciSparc to acquire vehicle importer AutoMax
|
Apr 11 |
SciSparc to Acquire AutoMax
|
Mar 27 |
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
|
Mar 21 |
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
|
Mar 18 |
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
|
Mar 14 |
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
|
Mar 12 |
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
|
Mar 12 |
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
|
Mar 8 |
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
|